Professor Nazir Lone

ICS Director of Research and Professor of Critical Care and Epidemiology

Nazir is a Professor of Critical Care and Epidemiology and one of the Intensive Care Society's Directors of Research. Nazir’s programme of research focuses on health services research and health care quality improvement for acutely ill patients. His research aims to directly improve the quality of care for patients before, during and after an episode of acute or critical illness through rigorously conducted research and engagement with key stakeholders. He has a particular research interest in epidemiological methods and using linked 'big' data, multimorbidity and end-of-life care in acute and critical care settings. 

His current programme of work includes NIHR-funded work to apply artificial intelligence (AI) methods in the context of multimorbidity (AIM-CISC) in which he co-leads work to develop AI tools to reduce adverse events. Furthermore, he leads Innovate UK funded work to improve multimorbidity recognition in emergency care settings using data analytics. 

: @ICULone

Professor Kenneth Rockwood

Professor of Geriatric Medicine , Dalhousie University & Nova Scotia Health

Kenneth Rockwood is Professor of Medicine (Division of Geriatric Medicine and Neurology) and Clinical Research Professor of Frailty and Aging at Dalhousie University and an active staff physician. A native of Newfoundland, he received his MD from Memorial University, and completed training in Internal Medicine at the University of Alberta and in Geriatric Medicine at Dalhousie University.

He is a leading authority on frailty, Professor Rockwood has more than 600 peer-reviewed publications and nine books to his credit. His original definition of frailty, The Rockwood Clinical Frailty Scale (CFS), first described in 2005 as a semiquantitative tool used to estimate an individual’s degree of frailty on a scale of 1 to 9, is used extensively across the world. Ken has many collaborations internationally, including work on younger people with frailty in the UK, a deprescribing clinical trial, an intergenerational dementia prevention trial, and a large multi centre study of frailty, all in Australia. He is also working with Cape Breton University on healthy aging and dementia prevention.